These then rapidly decay over the course of the first several months of life, leaving a windows of vulnerability for infectious diseases before infants are able to effectively generate their own antibodies (19,20)

On By msisig

These then rapidly decay over the course of the first several months of life, leaving a windows of vulnerability for infectious diseases before infants are able to effectively generate their own antibodies (19,20). 19thcentury (1). Certain infections disproportionately impact pregnant women. Pregnant women are either more susceptible or have more severe outcomes from infections with influenza, Listeria, malaria, varicella, hepatitis E, and herpes. Pregnant women are at higher risk for more severe influenza contamination, with higher rates of hospitalization and mortality compared to the general populace, and poor fetal outcomes (2). Listeria has a predilection for the placenta and causes meningoencephalitis as well as miscarriages and stillbirths (3,4). Malaria similarly has the potential to invade the placenta, is more severe in women in their first pregnancy, and causes anemia, preterm birth, and low birthweight (5,6). Varicella zoster computer virus contamination in the mother during pregnancy is associated with pneumonia, particularly in the third trimester, as well as risk of congenital varicella in the neonate (7). In studies from South Asia, hepatitis E may cause higher rates of fulminant hepatitis in pregnant women and is associated with increased mortality (8). Main herpes simplex virus contamination in pregnancy is associated with dissemination and fulminant hepatitis (9). Neonates also have increased susceptibility to infections and death, particularly in the developing world. Annually, 41% of all under-five child deaths are among neonates, and 12% of neonatal causes of death are due to contamination, including sepsis/pneumonia, tetanus, and diarrhea (10). Therefore, vaccination of the mother has the potential to protect the mother, the developing fetus, and the neonate from infections during a period of vulnerability. == IMMUNOLOGY OF MATERNAL VACCINATION == == THE IMMUNE SYSTEM DURING PREGNANCY == The classic theory of the immune system during pregnancy consists of an anti-inflammatory or Th2-type state that allows Ostarine (MK-2866, GTx-024) for fetal development, whereas a sudden shift towards a pro-inflammatory Th1-type immune response could lead to pregnancy complications, such as abortion and preterm birth (11). In recent years, it has been established that pregnancy is a much more complex interplay of both pro- and anti-inflammatory cytokines between the fetus and the mother. Recent studies have shown that a pro-inflammatory Th1-type tissue environment can be found in early healthy pregnancies and shifts to an anti-inflammatory state by Rabbit Polyclonal to ZNF682 the third trimester (12,13). Natural killer (NK) cells, macrophages, dendritic cells, and an expanding T regulatory cell populace have all been detected at the maternal-fetal interface and are theorized to play a beneficial role in successful fetal implantation, rather than increasing the risk of miscarriage (14,15). Cytokines, such as interleukin (IL-10), colony stimulating factor (CSF-1), and transforming growth factor- are essential for trophoblast invasion during the implantation process and are expressed by endometrial immune cells (16). These conflicting findings may be explained by considering pregnancy as a developmental process with different immunological stages rather than as a single homogeneous event. Rises in progesterone and estradiol lead to shifts in immunity as pregnancy progresses, with dampening of cell-mediated immunity, Th1 activity, and NK cell and B cell counts, and with increases in phagocytic activity, -defensin levels, and monocyte, dendritic-cell, and polymorphonuclear-cell counts (17). == PLACENTAL ANTIBODY TRANSFER == Placental transfer of IgG, preferentially IgG1, from mother to fetus generally begins in the second trimester and peaks during the third trimester so that infant Ostarine (MK-2866, GTx-024) antibody concentrations often exceed those Ostarine (MK-2866, GTx-024) of the mother by the time of birth (18). These then rapidly decay over the course of the first several months of life, leaving a windows of vulnerability for infectious diseases before infants are able to effectively generate their own antibodies (19,20). The concept of maternal vaccination is usually to boost antibody titers during pregnancy so that higher titers persist for.